Biomaterial Database

Further observations on oxytocin and oxytocic substance. 1959

R W HAWKER, and C F WALMSLEY, and V S ROBERTS, and P A ROBERTSON

UI	MeSH Term	Description	Entries
D007610	Kallikreins	Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77).	Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D010120	Oxytocics	Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157)	Oxytocic,Oxytocic Agent,Oxytocic Drug,Uterine Stimulant,Uterine Stimulants,Oxytocic Agents,Oxytocic Drugs,Oxytocic Effect,Oxytocic Effects,Agent, Oxytocic,Agents, Oxytocic,Drug, Oxytocic,Drugs, Oxytocic,Effect, Oxytocic,Effects, Oxytocic,Stimulant, Uterine,Stimulants, Uterine
D010121	Oxytocin	A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION.	Ocytocin,Pitocin,Syntocinon
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R W HAWKER, and C F WALMSLEY, and V S ROBERTS, and P A ROBERTSON

The oxytocin drip: some further experiences and observations.

January 1962, Lancet (London, England),

R W HAWKER, and C F WALMSLEY, and V S ROBERTS, and P A ROBERTSON

HEN OXYTOCIC ACTIVITIES OF OXYTOCIN AND 1-DEAMINO-OXYTOCIN.

January 1965, Endocrinology,

R W HAWKER, and C F WALMSLEY, and V S ROBERTS, and P A ROBERTSON

Oxytocic activity measurements in blood plasma with some observations on oxytocin disappearance rates in lactating cows.

January 1973, Bulletin de l'Academie polonaise des sciences. Serie des sciences biologiques,

R W HAWKER, and C F WALMSLEY, and V S ROBERTS, and P A ROBERTSON

[Further results on a myogenic inhibitory substance in the human uterus. On oxytocin antagonism of uterine substance].

January 1969, Gynaecologia. International monthly review of obstetrics and gynecology. Revue internationale mensuelle d'obstetrique et de gynecologie. Monatsschrift fur Geburtshilfe und Gynakologie,

R W HAWKER, and C F WALMSLEY, and V S ROBERTS, and P A ROBERTSON

Further observations on an inhibitory substance (nisin) from lactic streptococci.

July 1947, Lancet (London, England),

R W HAWKER, and C F WALMSLEY, and V S ROBERTS, and P A ROBERTSON

4-Threonine-oxytocin: a more active and specific oxytocic agent than oxytocin.

August 1970, Nature,

R W HAWKER, and C F WALMSLEY, and V S ROBERTS, and P A ROBERTSON

Oxytocin: oxytocic of choice in first trimester.

September 1980, The Medical journal of Australia,

R W HAWKER, and C F WALMSLEY, and V S ROBERTS, and P A ROBERTSON

Observations on the oxytocic property of human blood.

March 1948, Federation proceedings,